.

Nuvasive reported $33.07M in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbott ABT:US $ 2388M 524M
Abiomed ABMD:US $ 66.05M 1.05M
Atricure ATRC:US $ -13.66M 0.49M
Baxter International BAX:US $ 351M 188M
Becton, Dickinson and BDX:US $ 535M 117M
Boston Scientific BSX:US $ 423M 43M
Cardiovascular Systems CSII:US $ -9.48M 0.16M
Cooper Companies COO:US $ 140.6M 7.9M
Dexcom DXCM:US $ 77M 35.7M
Edwards Lifesciences EW:US $ 459.5M 20.7M
Globus Medical GMED:US $ 67.78M 21.33M
Haemonetics HAE:US $ 30.77M 11.57M
Hologic HOLX:US $ 263.9M 330.2M
Inogen INGN:US $ -2876000 10.71M
Insulet PODD:US $ -26.7M 64.6M
Integra Lifesciences IART:US $ 61.06M 13.6M
Intuitive Surgical ISRG:US $ 397.6M 10.5M
Johnson & Johnson JNJ:US $ 5840M 22M
Medtronic MDT:US $ 1125M 546M
Merit Medical Systems MMSI:US $ 23.26M 8.02M
Nuvasive NUVA:US $ 33.07M 21.14M
Stryker SYK:US $ 772M 325M
Tandem Diabetes Care TNDM:US $ -12.24M 3.1M
Teleflex TFX:US $ 135.16M 31.62M
Zimmer Biomet Holdings Inc ZBH:US $ 280.9M 82.5M